NCT03539198 2024-11-14
Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer
Mayo Clinic
Terminated
Clinical Trials
3 trialsNCT03402737 2021-02-18
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
University Hospital, Ghent
Phase NA Terminated
NCT02110992 2019-11-25
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
University of Cincinnati
Phase 1 Terminated